Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 37% ± 17% | |
fibroblast | 8 studies | 58% ± 25% | |
glial cell | 6 studies | 58% ± 27% | |
Schwann cell | 5 studies | 83% ± 12% | |
oligodendrocyte precursor cell | 4 studies | 33% ± 12% | |
pericyte | 4 studies | 41% ± 31% | |
melanocyte | 4 studies | 65% ± 20% | |
adipocyte | 3 studies | 26% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 35% | 305.88 | 625 / 1809 | 95% | 81.30 | 447 / 472 |
bladder | 95% | 1475.10 | 20 / 21 | 11% | 0.41 | 57 / 504 |
prostate | 74% | 1275.73 | 182 / 245 | 30% | 0.61 | 153 / 502 |
esophagus | 75% | 2637.56 | 1077 / 1445 | 27% | 1.57 | 49 / 183 |
heart | 100% | 5197.32 | 858 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 28.36 | 79 / 80 |
intestine | 86% | 3747.31 | 833 / 966 | 8% | 0.25 | 43 / 527 |
brain | 34% | 354.43 | 910 / 2642 | 43% | 1.84 | 304 / 705 |
stomach | 53% | 1232.98 | 189 / 359 | 14% | 0.60 | 39 / 286 |
adrenal gland | 31% | 317.51 | 80 / 258 | 33% | 2.40 | 77 / 230 |
pancreas | 2% | 13.34 | 6 / 328 | 56% | 2.36 | 100 / 178 |
blood vessel | 48% | 1098.71 | 645 / 1335 | 0% | 0 | 0 / 0 |
breast | 29% | 290.10 | 134 / 459 | 11% | 1.61 | 127 / 1118 |
lung | 23% | 175.68 | 134 / 578 | 11% | 0.47 | 124 / 1155 |
uterus | 26% | 366.16 | 45 / 170 | 5% | 0.18 | 24 / 459 |
liver | 16% | 101.79 | 37 / 226 | 15% | 0.69 | 62 / 406 |
adipose | 31% | 348.19 | 368 / 1204 | 0% | 0 | 0 / 0 |
ovary | 22% | 232.30 | 40 / 180 | 6% | 0.17 | 24 / 430 |
thymus | 21% | 148.17 | 135 / 653 | 2% | 0.03 | 11 / 605 |
spleen | 11% | 94.98 | 27 / 241 | 0% | 0 | 0 / 0 |
kidney | 6% | 37.82 | 5 / 89 | 5% | 0.23 | 41 / 901 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.18 | 4 / 45 |
muscle | 2% | 14.75 | 18 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007043 | Biological process | cell-cell junction assembly |
GO_0007275 | Biological process | multicellular organism development |
GO_0000902 | Biological process | cell morphogenesis |
GO_0034332 | Biological process | adherens junction organization |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0016477 | Biological process | cell migration |
GO_0044331 | Biological process | cell-cell adhesion mediated by cadherin |
GO_0016339 | Biological process | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0005912 | Cellular component | adherens junction |
GO_0005886 | Cellular component | plasma membrane |
GO_0016342 | Cellular component | catenin complex |
GO_0045296 | Molecular function | cadherin binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008013 | Molecular function | beta-catenin binding |
Gene name | CDH19 |
Protein name | Cadherin 19 Cadherin-19 |
Synonyms | UNQ478/PRO941 CDH7L2 |
Description | FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. |
Accessions | Q9H159 ENST00000580157.2 ENST00000579658.5 ENST00000454642.3 F8VVI9 J3KTP3 J3QS15 ENST00000262150.7 [Q9H159-1] ENST00000540086.5 [Q9H159-2] |